middle.news
Percheron Therapeutics Appoints Michael Baker as CEO to Lead Oncology Push
8:24am on Monday 10th of August, 2026 AEST
•
Biotechnology
Read Story
Percheron Therapeutics Appoints Michael Baker as CEO to Lead Oncology Push
8:24am on Monday 10th of August, 2026 AEST
Key Points
Dr James Garner to step down as CEO on 31 August 2026
Dr Michael Baker appointed CEO effective 5 October 2026
Baker’s remuneration includes reduced cash and performance-linked equity
Garner to remain on board as Non-Executive Director
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Percheron Therapeutics (ASX:PER)
OPEN ARTICLE